Ultragenyx Pharmaceutical Inc Company

Ultragenyx Pharmaceutical develops therapeutics for rare diseases, sometimes referred to as Orphan products. Ultragenyx is a efficient and effective development strategies are essential for success in the rare disease space, in which information may be incomplete or ambiguous, and few development precedents exist.
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States

Visit Website
info@ultragenyx.com
Register and Claim Ownership